Montana Compounding Pharmacy and Wellness Center (Montana Compounding Pharmacy), Missoula, MT
Is Montana Compounding Pharmacy and Wellness Center (Montana Compounding Pharmacy) registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Montana Compounding Pharmacy and Wellness Center (Montana Compounding Pharmacy) hold a Montana pharmacy license?
State board of pharmacy records for Montana are not checked: this index has not yet added that board’s records.
Has Montana Compounding Pharmacy and Wellness Center (Montana Compounding Pharmacy) had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter close-out (Feb 1, 2022), 1 state referral letter (Feb 1, 2022) and 1 FMD-145 letter (Feb 1, 2022) for Montana Compounding Pharmacy and Wellness Center (Montana Compounding Pharmacy). State board of pharmacy records for Montana are not checked: this index has not yet added that board’s records. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Montana Compounding Pharmacy; Montana Compounding Pharmacy and Wellness Center
- Location
- Missoula, MT
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 1
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Feb 1, 2022
- FDA Data Dashboard inspections
- 0 inspections; 0 published Form 483s
- State board records
- Not checked
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Montana Compounding Pharmacy dba Montana Compounding Pharmacy and Wellness Center, a 503A facility, with 4 dated actions.
| Document | |||
|---|---|---|---|
| Feb 1, 2022 | State referral letter | State Referral Letter Issued 02/01/2022 | Not linked by FDA |
| Feb 1, 2022 | Warning letter close-out | Warning Letter Close Out Issued 02/01/2022 | Not linked by FDA |
| Feb 1, 2022 | FMD-145 letter | FMD-145 Letter Issued 02/01/2022 | Not linked by FDA |
| Sep 22, 2021 | Form 483 | 483 Issued 09/22/2021 | FDA copy (archived) |
A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists Montana Compounding Pharmacy PC, Missoula, MT (FEI number 3011412185), matched to this page by exact name, city and state. It lists no classified inspection under this name at that site. Dashboard firm profile.
Form 483s FDA has published for this site
No published Form 483 for FEI 3011412185 was found in the dashboard’s list of published 483s on Nov 15, 2026. FDA publishes only some 483s, so this does not mean none was issued.
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA links 1 Form 483 PDF for Montana Compounding Pharmacy and Wellness Center (Montana Compounding Pharmacy), but no observation text is shown, for the reasons below.
Linked 483s whose text is not shown
- Sep 22, 2021: FDA document 154251: the FEI number and firm name on its cover do not match this page by the rule.
State board of pharmacy records
State board of pharmacy records for Montana are not checked: this index has not yet added that board’s records.
This page restates FDA’s lists. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
Records last pulled Nov 15, 2026. Every entry links to the original public record.